Depending on the context of the inflammation, IL-17 has a complicated role in IBD, with protective and/or pathogenic effects as evidenced by a recent study suggesting that IL-17 has a protective effect in the DSS- and AIEC-induced colitis models [76, 77]. This evidence concerns the gene IL17A and inflammatory bowel disease.